0001374135-11-000024.txt : 20110517 0001374135-11-000024.hdr.sgml : 20110517 20110517153043 ACCESSION NUMBER: 0001374135-11-000024 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110331 FILED AS OF DATE: 20110517 DATE AS OF CHANGE: 20110517 EFFECTIVENESS DATE: 20110517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: American BioCare, Inc. CENTRAL INDEX KEY: 0001096935 STANDARD INDUSTRIAL CLASSIFICATION: INVESTORS, NEC [6799] IRS NUMBER: 841517715 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-27775 FILM NUMBER: 11851312 BUSINESS ADDRESS: STREET 1: 1365 N. COURTENAY PARKWAY STREET 2: SUITE A CITY: MERRITT ISLAND STATE: FL ZIP: 32953 BUSINESS PHONE: 321-452-9091 MAIL ADDRESS: STREET 1: 1365 N. COURTENAY PARKWAY STREET 2: SUITE A CITY: MERRITT ISLAND STATE: FL ZIP: 32953 FORMER COMPANY: FORMER CONFORMED NAME: American Development & Investment Fund, Inc. DATE OF NAME CHANGE: 20060320 FORMER COMPANY: FORMER CONFORMED NAME: MNS EAGLE EQUITY GROUP INC / DATE OF NAME CHANGE: 20010621 NT 10-Q 1 formnt10q.htm AMERICAN BIOCARE, INC. FORM NT-10Q formnt10q.htm
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

814-1517721
(SEC File Number)

025362-10-4
CUSIP Number

(Check one): Form 10-K [  ] Form 20-F  [_] Form 11-K  [_] Form 10-Q [X ] Form 10-D [_] Form N-SAR [_] Form N-CSR [_]


         For Period Ended:  March 31, 2010

         [_]  Transition Report on Form 10-K
         [_]  Transition Report on Form 20-F
         [_]  Transition Report on Form 11-K
         [  ]  Transition Report on Form 10-Q
         [_]  Transition Report on Form N-SAR

         For the Transition Period Ended:

NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.


If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I -- REGISTRANT INFORMATION

AMERICAN BIOCARE, INC.
(Exact name of registrant as specified in its charter)

(Former Name if Applicable)

101 West Big Beaver Road, Suite 1400
Address of principal executive office (Street and Number

Troy, MI 48084
City, state and Zip Code

 
 
 

 


 
PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

      (a)
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

      (b)
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

      (c)
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III -- NARRATIVE

State below in reasonable detail why Form 10-K could not be filed within the prescribed time period.

Registrant has been unable to reconcile certain accounts in time to complete accurate financial reports and to provide all required information for its quarterly report. Accordingly, Registrant is unable to complete the preparation of its financial statements in time to complete the report on Form 10-Q on a timely basis.  The report will be filed on or before the fifth calendar day following the prescribed due date.

PART IV-- OTHER INFORMATION

(1)              Name and telephone number of person to contact in regard to this notification

Robert Hipple                 321                          452-9091
    (Name)                    (Area Code)         (Telephone Number)

(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
                                                                                                                                                   [X] Yes [_] No

(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?                                                                                                                                       [_] Yes [X] No
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 
AMERICAN BIOCARE, INC.
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

American Development & Investment Fund, Inc.

Date: May 16, 2011                                                                              By: /s/Gary D. Lewis
                                                                                                  Name: Gary D. Lewis
                                                                                                  Chairman and Chief Executive Officer